Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation

BACKGROUND: β-blockers (BBs) are considered primary therapy in stable heart failure (HF) with reduced ejection fraction (HFrEF) without atrial fibrillation (AF); evidence-based benefits of BB on outcome have been documented. However, BBs have not been shown to improve mortality or reduce hospital ad...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Korean Med Sci
Main Authors: Ahn, Min-Soo, Yoo, Byung-Su, Son, Jung-Woo, Yu, Min Heui, Kang, Dae Ryong, Lee, Hae-Young, Jeon, Eun-Seok, Kim, Jae-Joong, Chae, Shung Chull, Baek, Sang Hong, Kang, Seok-Min, Choi, Dong-Ju, Kim, Kye Hun, Cho, Myeong-Chan, Kim, Seong Yoon
פורמט: Artigo
שפה:Inglês
יצא לאור: The Korean Academy of Medical Sciences 2020
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7445305/
https://ncbi.nlm.nih.gov/pubmed/32830467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2020.35.e278
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים